As the obesity rate among people with type 1 diabetes rises, patients are taking popular weight loss drugs like Ozempic—and ...

GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a ...

Weight loss drugs like Ozempic gained popularity for managing obesity, diabetes, and related chronic conditions, a new study ...

In a plenary session at the annual American Academy of Neurology meeting, Paul Edison, MD, PhD, of Imperial College London in England, assessed how GLP-1 receptor agonists might influence cognitive ...

Five scientists won this year’s Breakthrough Prize in Life Sciences for their work on GLP-1 and the development of drugs for ...

While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...

A new USC study reveals that sucralose, a popular artificial sweetener, may trick the brain by triggering hunger-related ...